{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:49:43Z","timestamp":1764874183439,"version":"3.32.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-06072-5","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T08:21:00Z","timestamp":1731745260000},"page":"5935-5939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report: VEXAS syndrome with excellent response to treatment with azacitidine"],"prefix":"10.1007","volume":"103","author":[{"given":"Tzvika","family":"Porges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elli","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofir","family":"Wolach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iftach","family":"Sagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehonatan","family":"Sherf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itai","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"issue":"27","key":"6072_CR1","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMOA2026834\/SUPPL_FILE\/NEJMOA2026834_DISCLOSURES.PDF","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA et al (2020) Somatic mutations in UBA1 and severe adult-onset Autoinflammatory Disease. N Engl J Med 383(27):2628\u20132638. https:\/\/doi.org\/10.1056\/NEJMOA2026834\/SUPPL_FILE\/NEJMOA2026834_DISCLOSURES.PDF","journal-title":"N Engl J Med"},{"issue":"2","key":"6072_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/MOH.0000000000000750","volume":"30","author":"P Sujobert","year":"2023","unstructured":"Sujobert P, Heiblig M, Jamilloux Y (2023) VEXAS: where do we stand 2 years later? Curr Opin Hematol 30(2):64\u201369. https:\/\/doi.org\/10.1097\/MOH.0000000000000750","journal-title":"Curr Opin Hematol"},{"issue":"26","key":"6072_CR3","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1182\/BLOOD.2021011455","volume":"137","author":"PC Grayson","year":"2021","unstructured":"Grayson PC, Patel BA, Young NS (2021) VEXAS syndrome. Blood 137(26):3591\u20133594. https:\/\/doi.org\/10.1182\/BLOOD.2021011455","journal-title":"Blood"},{"issue":"26","key":"6072_CR4","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1182\/BLOOD.2020010177","volume":"137","author":"E Bourbon","year":"2021","unstructured":"Bourbon E, Heiblig M, Gerfaud Valentin M et al (2021) Therapeutic options in VEXAS syndrome: insights from a retrospective series. Blood 137(26):3682\u20133684. https:\/\/doi.org\/10.1182\/BLOOD.2020010177","journal-title":"Blood"},{"issue":"3","key":"6072_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/EJH.12311","volume":"93","author":"JJ Frietsch","year":"2014","unstructured":"Frietsch JJ, Dornaus S, Neumann T et al (2014) Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review. Eur J Haematol 93(3):247\u2013259. https:\/\/doi.org\/10.1111\/EJH.12311","journal-title":"Eur J Haematol"},{"key":"6072_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/J.LEUKRES.2016.02.005","volume":"43","author":"JB Fraison","year":"2016","unstructured":"Fraison JB, Mekinian A, Grignano E et al (2016) Efficacy of Azacitidine in Autoimmune and Inflammatory disorders associated with myelodysplastic syndromes and Chronic Myelomonocytic Leukemia. Leuk Res 43:13\u201317. https:\/\/doi.org\/10.1016\/J.LEUKRES.2016.02.005","journal-title":"Leuk Res"},{"issue":"2","key":"6072_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000446062","volume":"136","author":"O Wolach","year":"2016","unstructured":"Wolach O, Stone R (2016) Autoimmunity and inflammation in myelodysplastic syndromes. Acta Haematol 136(2):108\u2013117. https:\/\/doi.org\/10.1159\/000446062","journal-title":"Acta Haematol"},{"issue":"14","key":"6072_CR8","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1182\/BLOOD-2011-09-377044","volume":"119","author":"OC Goodyear","year":"2012","unstructured":"Goodyear OC, Dennis M, Jilani NY et al (2012) Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood 119(14):3361\u20133369. https:\/\/doi.org\/10.1182\/BLOOD-2011-09-377044","journal-title":"Blood"},{"issue":"4","key":"6072_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/BJH.17893","volume":"196","author":"T Comont","year":"2022","unstructured":"Comont T, Heiblig M, Rivi\u00e8re E et al (2022) Azacitidine for patients with vacuoles, E1 Enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry. Br J Haematol 196(4):969\u2013974. https:\/\/doi.org\/10.1111\/BJH.17893","journal-title":"Br J Haematol"},{"issue":"12","key":"6072_CR10","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1097\/HS9.0000000000000661","volume":"5","author":"MHGP Raaijmakers","year":"2021","unstructured":"Raaijmakers MHGP, Hermans M, Aalbers A et al (2021) Azacytidine Treatment for VEXAS Syndrome. Hemasphere 5(12):e661. https:\/\/doi.org\/10.1097\/HS9.0000000000000661","journal-title":"Hemasphere"},{"doi-asserted-by":"publisher","unstructured":"Kataoka A, Mizumoto C, Kanda J et al Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome. Int J Hematol Published Online January 14, 2023:1\u20136. https:\/\/doi.org\/10.1007\/S12185-023-03532-Y\/METRICS","key":"6072_CR11","DOI":"10.1007\/S12185-023-03532-Y\/METRICS"},{"issue":"5","key":"6072_CR12","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1093\/RHEUMATOLOGY\/KEAB866","volume":"61","author":"I Cordts","year":"2022","unstructured":"Cordts I, Hecker JS, Gauck D et al (2022) Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis. Rheumatology 61(5):e117\u2013e119. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEAB866","journal-title":"Rheumatology"},{"issue":"3","key":"6072_CR13","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/S00277-023-05611-W","volume":"103","author":"K Sockel","year":"2024","unstructured":"Sockel K, G\u00f6tze K, Ganster C et al (2024) VEXAS syndrome: complete molecular remission after hypomethylating therapy. Ann Hematol 103(3):993\u2013997. https:\/\/doi.org\/10.1007\/S00277-023-05611-W","journal-title":"Ann Hematol"},{"issue":"2","key":"6072_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/AJH.27169","volume":"99","author":"C Gurnari","year":"2024","unstructured":"Gurnari C, Pascale MR, Vitale A et al (2024) Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort. Am J Hematol 99(2):254\u2013262. https:\/\/doi.org\/10.1002\/AJH.27169","journal-title":"Am J Hematol"},{"issue":"6","key":"6072_CR15","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1182\/BLOODADVANCES.2023012478","volume":"8","author":"C Gurnari","year":"2024","unstructured":"Gurnari C, Koster L, Baaij L et al (2024) Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT. Blood Adv 8(6):1444\u20131448. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2023012478","journal-title":"Blood Adv"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06072-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06072-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06072-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:13:26Z","timestamp":1735866806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06072-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6072"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06072-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}